Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 7
1966 11
1967 10
1968 6
1969 5
1970 3
1971 6
1972 2
1973 2
1974 7
1975 3
1976 5
1977 6
1978 3
1979 13
1980 51
1981 147
1982 268
1983 254
1984 257
1985 214
1986 207
1987 199
1988 288
1989 326
1990 272
1991 329
1992 329
1993 346
1994 342
1995 396
1996 387
1997 380
1998 391
1999 396
2000 433
2001 445
2002 521
2003 537
2004 552
2005 512
2006 583
2007 667
2008 733
2009 727
2010 700
2011 678
2012 656
2013 687
2014 693
2015 702
2016 671
2017 625
2018 608
2019 324
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

16,730 results
Results by year
Filters applied: . Clear all
Page 1
Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults.
MacQueen G, Santaguida P, Keshavarz H, Jaworska N, Levine M, Beyene J, Raina P. MacQueen G, et al. Can J Psychiatry. 2017 Jan;62(1):11-23. doi: 10.1177/0706743716664885. Epub 2016 Sep 24. Can J Psychiatry. 2017. PMID: 27554483 Free PMC article. Review.
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
Popova V, Daly EJ, Trivedi M, Cooper K, Lane R, Lim P, Mazzucco C, Hough D, Thase ME, Shelton RC, Molero P, Vieta E, Bajbouj M, Manji H, Drevets WC, Singh JB. Popova V, et al. Am J Psychiatry. 2019 Jun 1;176(6):428-438. doi: 10.1176/appi.ajp.2019.19020172. Epub 2019 May 21. Am J Psychiatry. 2019. PMID: 31109201 Clinical Trial.
Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects.
Moaddel R, Shardell M, Khadeer M, Lovett J, Kadriu B, Ravichandran S, Morris PJ, Yuan P, Thomas CJ, Gould TD, Ferrucci L, Zarate CA. Moaddel R, et al. Psychopharmacology (Berl). 2018 Oct;235(10):3017-3030. doi: 10.1007/s00213-018-4992-7. Epub 2018 Aug 16. Psychopharmacology (Berl). 2018. PMID: 30116859 Free PMC article. Clinical Trial.
Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
Ionescu DF, Bentley KH, Eikermann M, Taylor N, Akeju O, Swee MB, Pavone KJ, Petrie SR, Dording C, Mischoulon D, Alpert JE, Brown EN, Baer L, Nock MK, Fava M, Cusin C. Ionescu DF, et al. J Affect Disord. 2019 Jan 15;243:516-524. doi: 10.1016/j.jad.2018.09.037. Epub 2018 Sep 17. J Affect Disord. 2019. PMID: 30286416 Clinical Trial.
Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis.
Zhou X, Ravindran AV, Qin B, Del Giovane C, Li Q, Bauer M, Liu Y, Fang Y, da Silva T, Zhang Y, Fang L, Wang X, Xie P. Zhou X, et al. J Clin Psychiatry. 2015 Apr;76(4):e487-98. doi: 10.4088/JCP.14r09204. J Clin Psychiatry. 2015. PMID: 25919841 Clinical Trial.
Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning.
Fava M, Okame T, Matsushima Y, Perry P, Weiller E, Baker RA. Fava M, et al. Int J Neuropsychopharmacol. 2017 Jan 1;20(1):22-30. doi: 10.1093/ijnp/pyw087. Int J Neuropsychopharmacol. 2017. PMID: 27784751 Free PMC article. Clinical Trial.
16,730 results
Jump to page
Feedback